When prostate cancer metastasizes to bone, it can become especially dangerous - not only with its action in the bone but, interestingly, with increased aggressiveness of the overall cancer itself. Now, research presented ...
Apr 16, 2018
0
5
Breast cancer that spreads often infiltrates bone, causing fractures and intense pain. In such cases, chemotherapy is ineffective because the environment of the bone protects the tumor, even as the drug has toxic side effects ...
Sep 27, 2017
0
240
The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid, showed that adding the cyclin-dependent kinase (CDK) 4/6 inhibitor abemaciclib to endocrine therapy improved progression-free survival compared ...
Sep 11, 2017
0
1
(HealthDay)—For patients with a primary diagnosis of hepatocellular cancer (HCC), imaging of the pelvis rarely provides additional pathologic information, according to a study published online June 14 in the Journal of ...
Jun 21, 2017
0
0
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) followed by quantitative scanning significantly improves image quality and detection of bone metastases ...
Jun 14, 2017
0
0
When cancer metastases, bone unwittingly offers a friendly place for tumor cell growth—only to have its hospitality betrayed by pathologic fractures, spinal cord compression, the need for bone surgery or irradiation, and ...
Apr 14, 2017
0
6
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for bone scintigraphy (scans to identify bone metastases) in patients with prostate or breast cancer. This is the ...
Apr 6, 2017
0
1
The American Society for Radiation Oncology (ASTRO) recently published an updated clinical guideline that underscores the safety and effectiveness of palliative radiation therapy (RT) for treating painful bone metastases. ...
Feb 14, 2017
0
0
(HealthDay)—Use of zoledronic acid every 12 weeks does not result in increased risk of skeletal events compared with use every four weeks among patients with bone metastases due to breast cancer, prostate cancer, or multiple ...
Jan 4, 2017
0
2
Researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL), led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL leads to a significant reduction ...
Sep 13, 2016
0
1
